Dr. Warren Pleskow, MD

NPI: 1942313036
Total Payments
$783,113
2024 Payments
$200.90
Companies
24
Transactions
183
Medicare Patients
3,026
Medicare Billing
$1.0M

Payment Breakdown by Category

Research$731,020 (93.3%)
Consulting$35,055 (4.5%)
Other$10,265 (1.3%)
Food & Beverage$3,578 (0.5%)
Travel$3,175 (0.4%)
Education$20.33 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $731,020 62 93.3%
Consulting Fee $35,055 5 4.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,265 2 1.3%
Food and Beverage $3,578 99 0.5%
Travel and Lodging $3,175 12 0.4%
Education $20.33 3 0.0%

Payments by Type

Research
$731,020
62 transactions
General
$52,093
121 transactions

Top Paying Companies

Company Total Records Latest Year
Hikma Pharmaceuticals USA $296,553 8 $0 (2020)
Teva Pharmaceuticals USA, Inc. $206,935 15 $0 (2020)
3M Company $154,690 2 $0 (2018)
Glenmark Pharmaceuticals Inc. $66,400 6 $0 (2017)
West-Ward Pharmaceuticals $31,883 2 $0 (2018)
Mylan Specialty L.P. $13,256 19 $0 (2020)
OptiNose US, Inc. $2,727 10 $0 (2019)
Chiesi USA, Inc. $2,435 3 $0 (2022)
Cipla USA Inc. $2,210 17 $0 (2019)
GlaxoSmithKline, LLC. $1,871 31 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $200.90 7 Regeneron Healthcare Solutions, Inc. ($103.23)
2023 $239.19 11 AstraZeneca Pharmaceuticals LP ($67.39)
2022 $2,576 11 Chiesi USA, Inc. ($2,435)
2021 $479.34 11 AstraZeneca Pharmaceuticals LP ($341.27)
2020 $69,147 22 Hikma Pharmaceuticals USA ($31,255)
2019 $393,005 55 Hikma Pharmaceuticals USA ($265,298)
2018 $91,496 37 3M Company ($55,248)
2017 $225,969 29 3M Company ($99,442)

All Payment Transactions

183 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
11/05/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $22.25 General
Category: RESPIRATORY
10/08/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $37.25 General
Category: INFLAMMATION AND IMMUNOLOGY
05/24/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $17.24 General
Category: Respiratory
05/07/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $33.42 General
Category: INFLAMMATION AND IMMUNOLOGY
02/27/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $32.56 General
Category: INFLAMMATION AND IMMUNOLOGY
02/15/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $30.74 General
Category: RESPIRATORY
02/13/2024 Novartis Pharmaceuticals Corporation XOLAIR (Drug) Food and Beverage In-kind items and services $27.44 General
Category: Pulmonary/Respiratory Diseases
11/14/2023 Novartis Pharmaceuticals Corporation XOLAIR (Drug) Food and Beverage In-kind items and services $27.88 General
Category: Pulmonary/Respiratory Diseases
11/09/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $29.64 General
Category: RESPIRATORY
10/31/2023 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $21.48 General
10/24/2023 PFIZER INC. EUCRISA (Drug), CIBINQO Food and Beverage In-kind items and services $20.94 General
Category: DERMATOLOGY
10/18/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $14.92 General
Category: Respiratory
09/20/2023 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $20.60 General
Category: INFLAMMATION AND IMMUNOLOGY
09/05/2023 LEO Pharma Inc. ADBRY (Biological) Food and Beverage In-kind items and services $27.94 General
Category: DERMATOLOGY
07/28/2023 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $23.35 General
Category: Respiratory
06/07/2023 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $13.42 General
Category: Respiratory
05/18/2023 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $23.32 General
Category: INFLAMMATION AND IMMUNOLOGY
04/19/2023 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $15.70 General
Category: Respiratory
10/27/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $19.57 General
Category: RESPIRATORY
10/27/2022 Novartis Pharmaceuticals Corporation XOLAIR (Biological) Food and Beverage In-kind items and services $16.43 General
Category: RESPIRATORY
10/03/2022 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $16.49 General
Category: Respiratory
08/06/2022 Chiesi USA, Inc. Cash or cash equivalent $401.00 Research
Study: CLI-05993AB8-02
08/06/2022 Chiesi USA, Inc. Cash or cash equivalent $266.48 Research
Study: CLI-05993AB8-02
08/06/2022 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $13.77 General
Category: Respiratory
08/04/2022 Chiesi USA, Inc. Cash or cash equivalent $1,767.68 Research
Study: CLI-05993AB8-02

Research Studies & Clinical Trials

Study Name Company Amount Records
Fluticasone Salmeterol Powder, 100mcg50mcg Multicenter Clinical Endpoint Study Hikma Pharmaceuticals USA $265,298 6
CSP-07-000034 3M Company $154,690 2
A Randomized, Multiple-Dose, Blinded, Placebo-Controlled, Parallel-Design, Multiple-Center, Clinical Study to Evaluate the Therapeutic Equivalence of Fluticasone Propionate and Salmeterol Inhalation Powder, 100 mcg/50 mcg to ADVAIR DISKUS 100/50 (Fluticasone Propionate/Salmeterol) Inhalation Powder, in Subjects With Asthma Teva Pharmaceuticals USA, Inc. $148,137 12
GSP 301-303 Glenmark Pharmaceuticals Inc. $66,400 6
ACT-2015-075-OAA Teva Pharmaceuticals USA, Inc. $58,783 2
Fluticasone Salmeterol Powder, 100mcg50mcg Multicenter Clinical Endpoint Study West-Ward Pharmaceuticals $31,883 2
CLI-05993AB8-02 Chiesi USA, Inc. $2,435 3
U-FS-MU-AS3120 Cipla USA Inc. $2,210 17
Ph2b moderate to severe high reversibility asthma Amgen Inc. $162.63 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 557 15,657 $1.6M $398,489
2022 16 681 17,145 $1.2M $363,448
2021 16 1,045 11,007 $248,516 $142,388
2020 17 743 9,454 $199,662 $109,621
Total Patients
3,026
Total Services
53,263
Medicare Billing
$1.0M
Procedure Codes
60

All Medicare Procedures & Services

60 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J2357 Injection, omalizumab, 5 mg Office 2023 15 10,110 $1.3M $306,126 23.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 136 400 $70,000 $27,857 39.8%
95165 Professional service for preparation and provision of 1 or more antigens Office 2023 37 1,553 $65,226 $20,465 31.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 90 140 $28,000 $13,351 47.7%
94375 Test to measure rate of airflow Office 2023 77 235 $23,970 $7,268 30.3%
95117 Professional service for multiple injections of allergen Office 2023 78 730 $25,550 $6,357 24.9%
95004 Test for allergy using allergenic extract Office 2023 24 1,735 $26,025 $6,176 23.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 34 34 $11,050 $4,451 40.3%
95024 Test for allergy using allergenic extract injected into skin Office 2023 20 456 $10,944 $3,332 30.4%
96372 Injection of drug or substance under skin or into muscle Office 2023 25 237 $33,945 $2,879 8.5%
36415 Insertion of needle into vein for collection of blood sample Office 2023 21 27 $495.00 $226.80 45.8%
J2357 Injection, omalizumab, 5 mg Office 2022 12 8,085 $977,402 $240,861 24.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 180 589 $64,480 $41,739 64.7%
95165 Professional service for preparation and provision of 1 or more antigens Office 2022 53 3,935 $57,140 $35,111 61.4%
95004 Test for allergy using allergenic extract Office 2022 34 2,377 $18,071 $8,644 47.8%
94375 Test to measure rate of airflow Office 2022 82 271 $15,266 $8,604 56.4%
95117 Professional service for multiple injections of allergen Office 2022 63 820 $20,598 $7,575 36.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 48 62 $8,620 $5,870 68.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 34 34 $7,600 $4,190 55.1%
95024 Test for allergy using allergenic extract injected into skin Office 2022 23 476 $4,284 $3,398 79.3%
96372 Injection of drug or substance under skin or into muscle Office 2022 22 184 $27,305 $2,352 8.6%
90662 Influenza vaccine split virus, preservative free Office 2022 30 30 $2,250 $2,056 91.4%
95115 Professional service for single injection of allergen Office 2022 17 182 $3,735 $1,423 38.1%
G0008 Administration of influenza virus vaccine Office 2022 30 30 $900.00 $882.00 98.0%
94010 Test to measure expiratory airflow and volume Office 2022 11 18 $978.00 $435.58 44.5%

About Dr. Warren Pleskow, MD

Dr. Warren Pleskow, MD is a Internal Medicine healthcare provider based in Encinitas, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942313036.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Warren Pleskow, MD has received a total of $783,113 in payments from pharmaceutical and medical device companies, with $200.90 received in 2024. These payments were reported across 183 transactions from 24 companies. The most common payment nature is "" ($731,020).

As a Medicare-enrolled provider, Pleskow has provided services to 3,026 Medicare beneficiaries, totaling 53,263 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Allergy & Immunology
  • Location Encinitas, CA
  • Active Since 08/16/2006
  • Last Updated 09/11/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1942313036

Products in Payments

  • Fluticasone Salmeterol (Drug) $297,181
  • Fluticasone Propionate and Salmeterol (Biological) $117,537
  • Budesonide/Formoterol fumarate dihydrate (Drug) $58,783
  • FLUTICASONE PROPIONATE AND SALMETEROL (Drug) $33,465
  • Fluticasone Propionate and Salmeterol (Drug) $30,600
  • Yupelri (Drug) $13,256
  • Xhance (Drug) $2,727
  • DUPIXENT (Biological) $466.03
  • NUCALA (Biological) $389.06
  • FASENRA (Biological) $338.20
  • FASENRA (Drug) $226.89
  • Haegarda (Biological) $205.13
  • XOLAIR (Biological) $162.75
  • EUCRISA (Drug) $140.79
  • DUPIXENT DUPILUMAB INJECTION (Biological) $125.10
  • CUVITRU (Biological) $124.71
  • TRELEGY ELLIPTA (Drug) $123.92
  • Prolastin-C (Biological) $121.08
  • XOLAIR (Drug) $55.32
  • SYMBICORT (Drug) $40.10

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Encinitas